Jim Simons Ginkgo Bioworks Holdings, Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 6,366,901 shares of DNA stock, worth $54.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,366,901Holding current value
$54.1 Million% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding DNA
# of Institutions
209Shares Held
716MCall Options Held
990KPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.21 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.18 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$593 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$357 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$267 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.9B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...